Results: 9

New laboratory perspectives for evaluation of vivax malaria infected patients: a useful tool for infection monitoring

Braz. j. infect. dis; 24 (2), 2020
ABSTRACT In recent years, the number of cases with severe Plasmodium vivax malaria has shown an increasing trend. It is, therefore, important to identify routine laboratory markers that best characterize the acute disease phase and can serve as a tool for clinical follow-up of patients. In a cohort study...

Evaluación de la calidad del diagnóstico de malaria en la red local de laboratorios y en los laboratorios intermedios en el contexto de la eliminación de la enfermedad en Ecuador

Biomédica (Bogotá); 39 (supl.2), 2019
Resumen Introducción. El cumplimiento de la meta de eliminación de la malaria en Ecuador en el 2020 exige contar con la capacidad requerida para el diagnóstico microscópico ajustado a los estándares de calidad de la Organización Mundial de la Salud (OMS) y de la Organización Panamericana de la S...

Asymptomatic plasmodium infection in a residual malaria transmission area in the atlantic forest region: implications for elimination

Abstract INTRODUCTION: Elimination of malaria in areas of interrupted transmission warrants careful case assessment to avoid the reintroduction of this disease. Occasional malaria cases are reported among visitors of the Atlantic Forest area of Brazil, while data on residents of this area are scarce. ...

Performance of an immuno-rapid malaria Pf/Pv rapid diagnostic test for malaria diagnosis in the Western Brazilian Amazon

Abstract INTRODUCTION: Rapid diagnostic tests (RDTs) for detecting Plasmodium antigens have become increasingly common worldwide. We aimed to evaluate the accuracy of the Immuno-Rapid Malaria Pf/Pv RDT in detecting Plasmodium vivax infection compared to standard thick blood smear (TBS) under microscopy...

Validation of the rapid test carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon

Abstract: INTRODUCTION: In the Brazilian Amazon, malaria infections are primarily caused by Plasmodium vivax. The only drug that kills the hypnozoite form of P. vivax is primaquine, thereby preventing relapse. However, treating glucose-6-phosphate dehydrogenase (G6PD)-deficient individuals with primaqui...

Plasmodium vivax: causa de malária grave

O presente estudo é um relato de caso de malária por Plasmodium vivax em paciente internado no Hospital Universitário de Mato Grosso do Sul. O objetivo do trabalho foi ressaltar a existência de casos de malária grave provocada por esta espécie do protozoário, visto que a epidemiologia envolvendo P...

Perfil laboratorial do paciente malárico
Laboratory profile of malarial patient

J. bras. med; 67 (4), 1994
Os autores estudam prospectivamente o perfil laboratorial pré-tratamento de 212 pacientes com malária, sendo 77 por P. falciparum, l12 por P. vivax e 23 por P.falciparum + P. vivax. Dentre as alteraçoes observadas, algumas foram igualmente distribuídas em todas as formas de malária: SGOT elevada em ...

Semiologia de maláricos näo-imunes ou parcialmente imunes
Semiology of non-immune or partially immune patients with malaria

J. bras. med; 67 (3), 1994
A semiologia de 356 pacientes maláricos no Rio Grande do Sul é estudada prospectivamente em sua fase pré-tratamento. Foram analisados 30 itens semiológicos entre sinais e sintomas com a finalidade de se avaliar o comportamento da malária nesta popupaçao nao-imune ou parcialmente imune....

Malaria por Plasmodium vivax: aspectos clínicos y hematológicos
Malaria due to Plasmodium vivax. Clinical and hematological aspects

Rev. méd. hered; 5 (3), 1994
Se reportan los hallazgos clínicos, de laboratorio e histopatológicos, presentes en 20 pacientes que ingresaron al Hospital Hipólito Unanue en el año 1984, con el diagnóstico de malaria. Se revisa la fisiopatología con énfasis en los casos de malaria por Plasmodium vivax. El agente etiológico má...